Immunoregulatory Pathways Involved in Inflammatory Bowel Disease. (Q38537820)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26111210%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

review article

1 reference

title

Immunoregulatory Pathways Involved in Inflammatory Bowel Disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26111210%20AND%20SRC:MED&resulttype=core&format=json

inflammatory bowel diseases

18 February 2020

main subject

0 references

author

Gabriela Fonseca-Camarillo

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26111210%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Jesus Yamamoto-Furusho

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26111210%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

author name string

Gabriela Fonseca-Camarillo

1

1 reference

3 September 2017

Jesús K Yamamoto-Furusho

2

1 reference

3 September 2017

publication date

1 September 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26111210%20AND%20SRC:MED&resulttype=core&format=json

Inflammatory Bowel Diseases

18 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26111210%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26111210%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26111210%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

page(s)

2188-2193

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26111210%20AND%20SRC:MED&resulttype=core&format=json

Inflammatory Bowel Disease

18 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000477

Mechanisms of Disease: pathogenesis of Crohn's disease and ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000477

Dysregulation of mucosal immune response in pathogenesis of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000477

Inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000477

IL-10-- and IL-20--expressing epithelial and inflammatory cells are increased in patients with ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000477

Indoleamine 2,3-dioxygenase: expressing cells in inflammatory bowel disease-a cross-sectional study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000477

Innate and adaptive immunity in inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000477

Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000477

Regulatory T cells and mechanisms of immune system control

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000477

IL-35 is a novel responsive anti-inflammatory cytokine--a new system of categorizing anti-inflammatory cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000477

Regulation and functions of the IL-10 family of cytokines in inflammation and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000477

Interleukin-35 mediates mucosal immune responses that protect against T-cell-dependent colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000477

Foxp3+ regulatory T cells, Th17 effector cells, and cytokine environment in inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000477

Phenotypic and functional features of human Th17 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000477

Regulatory B cells in autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000477

Regulatory B cells: Evidence, developmental origin and population diversity

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000477

Suppressive role of B cells in chronic colitis of T cell receptor alpha mutant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000477

IL-10 family of cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000477

The extended IL-10 superfamily: IL-10, IL-19, IL-20, IL-22, IL-24, IL-26, IL-28, and IL-29.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000477

Cloning, expression and initial characterization of interleukin-19 (IL-19), a novel homologue of human interleukin-10 (IL-10)

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000477

IL-19 induces production of IL-6 and TNF-alpha and results in cell apoptosis through TNF-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000477

The Th17 cytokine IL-22 induces IL-20 production in keratinocytes: a novel immunological cascade with potential relevance in psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000477

The interleukin-10 family of cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000477

Interleukin 20: discovery, receptor identification, and role in epidermal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000477

The expression of IL-20 and IL-24 and their shared receptors are increased in rheumatoid arthritis and spondyloarthropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000477

Interleukin-20 antibody is a potential therapeutic agent for experimental arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000477

Cytokines: IL-20 - a new effector in skin inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000477

Maturing dendritic cells are an important source of IL-29 and IL-20 that may cooperatively increase the innate immunity of keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000477

Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000477

IL-19, IL-20 and IL-24: potential therapeutic targets for autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000477

Expression of IL-24, an activator of the JAK1/STAT3/SOCS3 cascade, is enhanced in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000477

The role of the novel Th17 cytokine IL-26 in intestinal inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000477

IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000477

IL-35 stimulation of CD39+ regulatory T cells confers protection against collagen II-induced arthritis via the production of IL-10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000477

IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000477

Identification and initial characterization of four novel members of the interleukin-1 family

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000477

Intestinal expression of the anti-inflammatory interleukin-1 homologue IL-37 in pediatric inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000477

Immunobiology of IL-37: mechanism of action and clinical perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000477

IL-37 inhibits the production of inflammatory cytokines in peripheral blood mononuclear cells of patients with systemic lupus erythematosus: its correlation with disease activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000477

Interleukin-37 is increased in ankylosing spondylitis patients and associated with disease activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000477

TH9 cells that express the transcription factor PU.1 drive T cell–mediated colitis via IL-9 receptor signaling in intestinal epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000477

Interleukins Involved in Inflammatory Bowel Disease as New Therapeutic Targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000477

Expression of interleukin (IL)-19 and IL-24 in inflammatory bowel disease patients: a cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000477

Protective role of interleukin-19 gene polymorphisms in patients with ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000477

Colonic epithelial upregulation of interleukin 22 (IL-22) in patients with ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000477

Role of the interleukin 24 in patients with ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000477